Travere Therapeutics, Inc. (TVTX)
About Travere Therapeutics, Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $490.7M
- Net income
- -$25.5M
- Total assets
- $605.2M
- Market cap
- $5.3B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.3B
- Shares outstanding
- 104.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 23, 2003
Travere Therapeutics, Inc. (TVTX) Stock Price
- Reported a net loss of $25.5M in FY2025.
- Trading 25% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Travere Therapeutics, Inc..
Write a review
News about Travere Therapeutics, Inc.
News & sentiment via Polygon.io
Travere Therapeutics, Inc.: frequently asked questions
Is Travere Therapeutics, Inc. an American company?
Travere Therapeutics, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Travere Therapeutics, Inc. headquartered?
Travere Therapeutics, Inc. is headquartered in San Diego, California, United States.
Is Travere Therapeutics, Inc. publicly traded?
Yes — Travere Therapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol TVTX on the NASDAQ.
What does Travere Therapeutics, Inc. do?
Travere Therapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
